|
Medical Science Liaisons Manager
|
Torun, PL
|
Feb 20, 2025
|
1557
|
|
|
Intern, Real Word Evidence - Summer 2025
|
Cary, NC, US
|
Feb 20, 2025
|
4991
|
|
|
Intern, Marketing - Summer 2025
|
Cary, NC, US
|
Feb 19, 2025
|
4965
|
|
|
Global Marketing: Lead AIM Insights
|
Boston, MA, US
|
Feb 19, 2025
|
5085
|
|
|
Marketing Trainee Special Care
|
Barcelona, ES
|
Feb 19, 2025
|
5202
|
|
|
Data Operations Analyst
|
Cary, NC, US
|
Feb 19, 2025
|
5231
|
|
|
Business Systems Analyst
|
Cary, NC, US
|
Feb 19, 2025
|
5230
|
|
|
Real World Evidence, Contractor
|
Cary, NC, US
|
Feb 19, 2025
|
5195
|
|
|
Business Analyst/Data Master
|
Prague, CZ
|
Feb 18, 2025
|
5064
|
|
|
Sr. Director, Global Portfolio Strategy HIDO, Rare
|
Boston, MA, US
|
Feb 15, 2025
|
5071
|
|
|
Market Access Manager Tender & Value (all genders)
|
DE
|
Feb 15, 2025
|
5089
|
|
|
Medical Lead Rare Diseases
|
Amsterdam or Brussels, NL
|
Feb 15, 2025
|
5002
|
|
|
Medical Scientific Liaison, Special Care EOLIS - Madrid
|
Madrid, ES
|
Feb 15, 2025
|
5087
|
|
|
Head of Medical Affairs (all genders), Rare Disease, Germany
|
DE
|
Feb 15, 2025
|
5088
|
|
|
Marketing Solution Partner
|
Barcelona, ES
|
Feb 13, 2025
|
5072
|
|
|
Global Brand Leader Pulmonary Arterial Hypertension
|
Parma, IT
|
Feb 13, 2025
|
5201
|
|
|
Associate Medical Director, Hematology and Immunology
|
Boston, MA, US
|
Feb 12, 2025
|
4985
|
|
|
Medical Scientific Liaison, Special Care EOLIS
|
Barcelona, ES
|
Feb 12, 2025
|
5028
|
|
|
Senior Medical Science Liaison - AIR, West
|
Las Vegas, NV, US
|
Feb 11, 2025
|
4623
|
|
|
Project Manager Rare Diseases
|
Amsterdam, NL
|
Feb 11, 2025
|
5198
|
|
|
Medical Scientific Liaison Manager (all genders) RCT Essen
|
DE
|
Feb 10, 2025
|
5192
|
|
|
National Account Director, Medicaid, Global Rare Diseases
|
Boston, MA, US
|
Feb 8, 2025
|
5042
|
|
|
Sr. Manager, Medical Communications - AIR
|
Cary, NC, US
|
Feb 8, 2025
|
4949
|
|
|
Product Manager, Curosurf
|
Cary, NC, US
|
Feb 7, 2025
|
5023
|
|
|
Working Student (all genders) Marketing, Digital Content & Communication
|
DE
|
Feb 7, 2025
|
5034
|
|
